The importance of B-cells in preventing cancer development has been illustrated in a long-term follow-up study on the effects of B-cell depletion after anti-CD20 (Rituximab) treatment, where a lack of B-cells was linked to the development of secondary malignancies [66]. This evidence concerns the gene MS4A1 and cancer.